Malaysia
Regulatory . Certification . Licensing . Assurance
Our Markets
Why Malaysia
Malaysia's pharmaceutical industry is a rising star in Southeast Asia, contributing significantly to the country's economy and healthcare landscape. With a market exceeding MYR6 billion and projected to reach MYR10 billion by 2024, it's a sector brimming with potential from rising healthcare demand of an aging population and increasing disposable incomes.
​
Government support such as tax breaks and special economic zones incentivize industry growth. The industry is driven by increasing demand for affordable alternatives to brand-name medications and Innovative products to address unmet medical needs.
​
The National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia. Malaysia Drug Control Authority, governs the registration of Prescription medicines, Essential drugs, Over-the-counter (OTC) products, Traditional medicines, Health/food supplements and Cosmetics, while the Medical Device Authority (MDA) controls the Medical Devices sector.
The regulatory environment in Malaysia can be complex and time-consuming, which can hinder the supply of new drugs and medical devices to the market.​Despite the challenges, the future of the Malaysian pharmaceutical industry is bright poised for continued expansion with the government committed to supporting the industry.
